In my follow, notes Dr Talal Khan, CEO at Khan Longevity Care (pictured), many sufferers describe a discount in what is commonly referred to as “meals noise” — these persistent or intrusive ideas about meals.
They might report fewer impulsive consuming choices, much less urgency round cravings and a larger potential to regulate their decisions.
Responses range significantly from individual to individual, however these observations have raised an intriguing query: may GLP-1 drugs additionally affect cravings past meals?
Researchers at the moment are finding out whether or not drugs resembling semaglutide could have an effect on alcohol use, nicotine cravings and doubtlessly different reward-driven behaviours.
GLP-1 (glucagon-like peptide-1) is a naturally occurring hormone concerned in blood sugar regulation, urge for food and satiety.
GLP-1 receptor agonists mimic this signalling, thereby serving to to scale back meals consumption and enhance metabolic management.
